BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurunathan S, Kang MH, Qasim M, Kim JH. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer. Int J Mol Sci 2018;19:E3264. [PMID: 30347840 DOI: 10.3390/ijms19103264] [Cited by in Crossref: 104] [Cited by in F6Publishing: 114] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT. Pharmaceutics 2022;14:1817. [DOI: 10.3390/pharmaceutics14091817] [Reference Citation Analysis]
2 Alshememry AK, Alsaleh NB, Alkhudair N, Alzhrani R, Alshamsan A. Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview. Front Pharmacol 2022;13:933457. [DOI: 10.3389/fphar.2022.933457] [Reference Citation Analysis]
3 Barzegar Behrooz A, Talaie Z, Syahir A. Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable. Pharmaceutics 2022;14:1697. [DOI: 10.3390/pharmaceutics14081697] [Reference Citation Analysis]
4 Harris R. The PEGylated and non-PEGylated interaction of the anticancer drug 5-fluorouracil with paramagnetic Fe3O4 nanoparticles as drug carrier. Journal of Molecular Liquids 2022;360:119515. [DOI: 10.1016/j.molliq.2022.119515] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Younis NK, Roumieh R, Bassil EP, Ghoubaira JA, Kobeissy F, Eid AH. Nanoparticles: attractive tools to treat colorectal cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.08.006] [Reference Citation Analysis]
6 Salvanou E, Kolokithas-ntoukas A, Liolios C, Xanthopoulos S, Paravatou-petsotas M, Tsoukalas C, Avgoustakis K, Bouziotis P. Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents. Nanomaterials 2022;12:2490. [DOI: 10.3390/nano12142490] [Reference Citation Analysis]
7 Ahmad MZ, Alasiri AS, Alasmary MY, Abdullah MM, Ahmad J, Abdel Wahab BA, M Alqahtani SA, Pathak K, Mustafa G, Khan MA, Saikia R, Gogoi U. Emerging advances in nanomedicine for breast cancer immunotherapy: opportunities and challenges. Immunotherapy 2022. [PMID: 35852105 DOI: 10.2217/imt-2021-0348] [Reference Citation Analysis]
8 Fatfat Z, Fatfat M, Gali-Muhtasib H. Micelles as potential drug delivery systems for colorectal cancer treatment. World J Gastroenterol 2022; 28(25): 2867-2880 [DOI: 10.3748/wjg.v28.i25.2867] [Reference Citation Analysis]
9 Renault-Mahieux M, Mignet N, Seguin J, Alhareth K, Paul M, Andrieux K. Co-encapsulation of flavonoids with anti-cancer drugs: a challenge ahead. Int J Pharm 2022;:121942. [PMID: 35728717 DOI: 10.1016/j.ijpharm.2022.121942] [Reference Citation Analysis]
10 Harris R. Simulation study on the physicochemical properties of Fe3O4 nanoparticles as drug delivery vehicles for dopamine replacement therapy of Parkinson’s disease. Materials Today Communications 2022;31:103829. [DOI: 10.1016/j.mtcomm.2022.103829] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zeng Z, Gao H, Chen C, Xiao L, Zhang K. Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy. Front Chem 2022;10:881812. [DOI: 10.3389/fchem.2022.881812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chelladurai M, Margavelu G, Vijayakumar S, González-sánchez ZI, Vijayan K, Sahadevan R. Preparation and characterization of amine-functionalized mupirocin-loaded zinc oxide nanoparticles: A potent drug delivery agent in targeting human epidermoid carcinoma (A431) cells. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103244] [Reference Citation Analysis]
13 Li Y, Jiang Y, Zheng Z, Du N, Guan S, Guo W, Tang X, Cui J, Zhang L, Liu K, Yu Q, Gan Z. Co-Delivery of Precisely Prescribed Multi-Prodrug Combination by an Engineered Nanocarrier enables Efficient Individualized Cancer Chemotherapy. Adv Mater 2022;34:e2110490. [PMID: 35044690 DOI: 10.1002/adma.202110490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zhang L, Jia H, Liu X, Zou Y, Sun J, Liu M, Jia S, Liu N, Li Y, Wang Q. Heptamethine Cyanine–Based Application for Cancer Theranostics. Front Pharmacol 2022;12:764654. [DOI: 10.3389/fphar.2021.764654] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rehman MU, Khan A, Imtiyaz Z, Ali S, Makeen HA, Rashid S, Arafah A. Current Nano-therapeutic Approaches Ameliorating Inflammation in Cancer Progression. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Farhoudi L, Kesharwani P, Majeed M, Johnston TP, Sahebkar A. Polymeric nanomicelles of curcumin: Potential applications in cancer. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Bassiony H, El-Ghor AA, Salaheldin TA, Sabet S, Mohamed MM. Tissue Distribution, Histopathological and Genotoxic Effects of Magnetite Nanoparticles on Ehrlich Solid Carcinoma. Biol Trace Elem Res 2022. [PMID: 35032291 DOI: 10.1007/s12011-022-03102-z] [Reference Citation Analysis]
18 He X, Chen F, Chang Z, Waqar K, Hu H, Zheng X, Wang Y, Dong WF, Yang C. Silver Mesoporous Silica Nanoparticles: Fabrication to Combination Therapies for Cancer and Infection. Chem Rec 2022;:e202100287. [PMID: 35020240 DOI: 10.1002/tcr.202100287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gagliardi A, Voci S, Bonacci S, Iriti G, Procopio A, Fresta M, Cosco D. SCLAREIN (SCLAREol contained in zeIN) nanoparticles: Development and characterization of an innovative natural nanoformulation. Int J Biol Macromol 2021;193:713-20. [PMID: 34717977 DOI: 10.1016/j.ijbiomac.2021.10.184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhao CC, Zhang CG, Sun X, Guo Q, Liu J, Liu Y, Hao YN, Feng G, Yang L, Liu H, Liu J. Paclitaxel-based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis. Cancer Sci 2021. [PMID: 34859546 DOI: 10.1111/cas.15230] [Reference Citation Analysis]
21 Meylina L, Muchtaridi M, Joni IM, Mohammed AFA, Wathoni N. Nanoformulations of α-Mangostin for Cancer Drug Delivery System. Pharmaceutics 2021;13:1993. [PMID: 34959275 DOI: 10.3390/pharmaceutics13121993] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Rio ISR, Rodrigues ARO, Rodrigues JM, Queiroz MRP, Calhelha RC, Ferreira ICFR, Almeida BG, Pires A, Pereira AM, Araújo JP, Castanheira EMS, Coutinho PJG. Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy. Pharmaceutics 2021;13:1905. [PMID: 34834322 DOI: 10.3390/pharmaceutics13111905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Tarannum M, Hossain MA, Holmes B, Yan S, Mukherjee P, Vivero-Escoto JL. Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer. Small 2021;:e2104449. [PMID: 34758094 DOI: 10.1002/smll.202104449] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
24 Askar MA, Thabet NM, El-Sayyad GS, El-Batal AI, Abd Elkodous M, El Shawi OE, Helal H, Abdel-Rafei MK. Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core-Shell-Radiosensitizer for Breast Cancer Therapy. Cancers (Basel) 2021;13:5571. [PMID: 34771733 DOI: 10.3390/cancers13215571] [Reference Citation Analysis]
25 Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, Gangadharappa HV, Pardakhty A, Mehrbani M, Dell'Agli M, Nematollahi MH. Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature. Int J Nanomedicine 2021;16:6983-7022. [PMID: 34703224 DOI: 10.2147/IJN.S318416] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
26 Gaur M, Misra C, Yadav AB, Swaroop S, Maolmhuaidh FÓ, Bechelany M, Barhoum A. Biomedical Applications of Carbon Nanomaterials: Fullerenes, Quantum Dots, Nanotubes, Nanofibers, and Graphene. Materials (Basel) 2021;14:5978. [PMID: 34683568 DOI: 10.3390/ma14205978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kumar K, Chawla R. Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer. Journal of Drug Delivery Science and Technology 2021;65:102677. [DOI: 10.1016/j.jddst.2021.102677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Wu Z, Xu K, Min J, Chen M, Shen L, Xu J, Jiang Q, Han G, Pan L, Li H. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis. J Appl Biomater Funct Mater 2020;18:2280800020962629. [PMID: 33155513 DOI: 10.1177/2280800020962629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Karade VC, Patil RB, Parit SB, Kim JH, Chougale AD, Dawkar VV. Insights into Shape-Based Silver Nanoparticles: A Weapon to Cope with Pathogenic Attacks. ACS Sustainable Chem Eng 2021;9:12476-507. [DOI: 10.1021/acssuschemeng.1c03797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
30 Aboyewa JA, Sibuyi NRS, Meyer M, Oguntibeju OO. Green Synthesis of Metallic Nanoparticles Using Some Selected Medicinal Plants from Southern Africa and Their Biological Applications. Plants (Basel) 2021;10:1929. [PMID: 34579460 DOI: 10.3390/plants10091929] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
31 C de S L Oliveira AL, Schomann T, de Geus-Oei LF, Kapiteijn E, Cruz LJ, de Araújo Junior RF. Nanocarriers as a Tool for the Treatment of Colorectal Cancer. Pharmaceutics 2021;13:1321. [PMID: 34452282 DOI: 10.3390/pharmaceutics13081321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Takács A, Szász Z, Kalabay M, Bárány P, Csámpai A, Hegyesi H, Láng O, Lajkó E, Kőhidai L. The Synergistic Activity of Bortezomib and TIC10 against A2058 Melanoma Cells. Pharmaceuticals (Basel) 2021;14:820. [PMID: 34451917 DOI: 10.3390/ph14080820] [Reference Citation Analysis]
33 Hu J, Yuan Q, Dong X, Cheng Y, Yuan L, Dai J, Xia F, Lou X. Modular‐Peptides‐Based Ternary Complex for Precisely Tracking the Targeted Process and Delivery of Gene/Chemo‐Drug. Adv Optical Mater 2021;9:2100966. [DOI: 10.1002/adom.202100966] [Reference Citation Analysis]
34 Lôbo GCNB, Paiva KLR, Silva ALG, Simões MM, Radicchi MA, Báo SN. Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy. Pharmaceutics 2021;13:1167. [PMID: 34452128 DOI: 10.3390/pharmaceutics13081167] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Seyedi F, Torabizadeh SA, Naeimi A. Radioprotective effect of a novel and green bio-nanohybrid, chitosan/silver/cobalt complex, based on Ferulago angulate plant. Biotechnol Appl Biochem 2021. [PMID: 34309897 DOI: 10.1002/bab.2228] [Reference Citation Analysis]
36 Eldesouky HE, Lanman NA, Hazbun TR, Seleem MN. Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs. Virulence 2020;11:1466-81. [PMID: 33100149 DOI: 10.1080/21505594.2020.1838741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
37 Taherian A, Esfandiari N, Rouhani S. Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00086-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mbugua SN, Njenga LW, Odhiambo RA, Wandiga SO, Onani MO. Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review. Curr Top Med Chem 2021;21:28-47. [PMID: 32814532 DOI: 10.2174/1568026620666200819160213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Abdel Fadeel DA, Hanafy MS, Kelany NA, Elywa MA. Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model. Heliyon 2021;7:e07370. [PMID: 34235286 DOI: 10.1016/j.heliyon.2021.e07370] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
40 Miyazawa T, Itaya M, Burdeos GC, Nakagawa K, Miyazawa T. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology. Int J Nanomedicine 2021;16:3937-99. [PMID: 34140768 DOI: 10.2147/IJN.S298606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
41 Habibi Khorassani SM, Ghodsi F, Arezomandan H, Shahraki M, Omidikia N, Hashemzaei M, Heidari Majd M. In Vitro Apoptosis Evaluation and Kinetic Modeling onto Cyclodextrin-Based Host–Guest Magnetic Nanoparticles Containing Methotrexate and Tamoxifen. BioNanoSci 2021;11:667-77. [DOI: 10.1007/s12668-021-00877-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Buskaran K, Hussein MZ, Moklas MAM, Masarudin MJ, Fakurazi S. Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application. Int J Mol Sci 2021;22:5786. [PMID: 34071389 DOI: 10.3390/ijms22115786] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
43 Seth R, Kuppalli SS, Nadav D, Chen G, Gulati A. Recent Advances in Peripheral Opioid Receptor Therapeutics. Curr Pain Headache Rep 2021;25:46. [PMID: 33970352 DOI: 10.1007/s11916-021-00951-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
45 Chaudhary S, Singh A, Kumar P, Kaushik M. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology. J Biochem Mol Toxicol 2021;35:e22784. [PMID: 33826765 DOI: 10.1002/jbt.22784] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
46 Voci S, Gagliardi A, Molinaro R, Fresta M, Cosco D. Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels. Gels 2021;7:33. [PMID: 33804970 DOI: 10.3390/gels7020033] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
47 Chen Q, Sun S, Lin H, Li Z, Wu A, Liu X, Wu FG, Zhang W. Supra-Carbon Dots Formed by Fe3+-Driven Assembly for Enhanced Tumor-Specific Photo-Mediated and Chemodynamic Synergistic Therapy. ACS Appl Bio Mater 2021;4:2759-68. [PMID: 35014315 DOI: 10.1021/acsabm.0c01663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Karade VC, Sharma A, Dhavale RP, Dhavale RP, Shingte SR, Patil PS, Kim JH, Zahn DRT, Chougale AD, Salvan G, Patil PB. APTES monolayer coverage on self-assembled magnetic nanospheres for controlled release of anticancer drug Nintedanib. Sci Rep 2021;11:5674. [PMID: 33707549 DOI: 10.1038/s41598-021-84770-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Khochaiche A, Westlake M, O'Keefe A, Engels E, Vogel S, Valceski M, Li N, Rule KC, Horvat J, Konstantinov K, Rosenfeld A, Lerch M, Corde S, Tehei M. First extensive study of silver-doped lanthanum manganite nanoparticles for inducing selective chemotherapy and radio-toxicity enhancement. Mater Sci Eng C Mater Biol Appl 2021;123:111970. [PMID: 33812598 DOI: 10.1016/j.msec.2021.111970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Mittal P, Saharan A, Verma R, Altalbawy FMA, Alfaidi MA, Batiha GE, Akter W, Gautam RK, Uddin MS, Rahman MS. Dendrimers: A New Race of Pharmaceutical Nanocarriers. Biomed Res Int 2021;2021:8844030. [PMID: 33644232 DOI: 10.1155/2021/8844030] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
51 Hajari MA, Baheri Islami S, Chen X. A numerical study on tumor-on-chip performance and its optimization for nanodrug-based combination therapy. Biomech Model Mechanobiol 2021;20:983-1002. [PMID: 33521884 DOI: 10.1007/s10237-021-01426-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Armanetti P, Chillà A, Margheri F, Biagioni A, Menichetti L, Margheri G, Ratto F, Centi S, Bianchini F, Severi M, Traversi R, Bani D, Lulli M, Del Rosso T, Mocali A, Rovida E, Del Rosso M, Fibbi G, Laurenzana A. Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma. Adv Sci (Weinh) 2021;8:2001175. [PMID: 33643785 DOI: 10.1002/advs.202001175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
53 Reboredo C, González-Navarro CJ, Martínez-Oharriz C, Martínez-López AL, Irache JM. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes. Int J Pharm 2021;597:120287. [PMID: 33524523 DOI: 10.1016/j.ijpharm.2021.120287] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
54 Grześkowiak BF, Maziukiewicz D, Kozłowska A, Kertmen A, Coy E, Mrówczyński R. Polyamidoamine Dendrimers Decorated Multifunctional Polydopamine Nanoparticles for Targeted Chemo- and Photothermal Therapy of Liver Cancer Model. Int J Mol Sci 2021;22:E738. [PMID: 33451063 DOI: 10.3390/ijms22020738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Kolašinac R, Bier D, Schmitt L, Yabluchanskiy A, Neumaier B, Merkel R, Csiszár A. Delivery of the Radionuclide 131I Using Cationic Fusogenic Liposomes as Nanocarriers. Int J Mol Sci 2021;22:E457. [PMID: 33466417 DOI: 10.3390/ijms22010457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Anani T, Rahmati S, Sultana N, David AE. MRI-traceable theranostic nanoparticles for targeted cancer treatment. Theranostics 2021;11:579-601. [PMID: 33391494 DOI: 10.7150/thno.48811] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
57 Pang C, Fan KS, Wei L, Kolar MK. Gene therapy in wound healing using nanotechnology. Wound Repair Regen 2021;29:225-39. [PMID: 33377593 DOI: 10.1111/wrr.12881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
58 Attri A, Thakur D, Kaur T, Sensale S, Peng Z, Kumar D, Singh RP. Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon's Trident against Cancer? Mol Pharm 2021;18:124-47. [PMID: 33346663 DOI: 10.1021/acs.molpharmaceut.0c00730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
59 Eldesouky HE, Salama EA, Lanman NA, Hazbun TR, Seleem MN. Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris. Antimicrob Agents Chemother 2020;65:e00684-20. [PMID: 33046487 DOI: 10.1128/AAC.00684-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
60 Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, Sobolev A, Freixanet M, Puntes V, Plotniece A, Dusinska M, Cimpan MR, Gabelova A, Smolkova B. Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives. Cancers (Basel) 2020;12:E3622. [PMID: 33287297 DOI: 10.3390/cancers12123622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
61 Deligiorgi MV, Liapi C, Trafalis DT. How Far Are We from Prescribing Fasting as Anticancer Medicine? Int J Mol Sci 2020;21:E9175. [PMID: 33271979 DOI: 10.3390/ijms21239175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
62 Mediratta K, El-Sahli S, D'Costa V, Wang L. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. Cancers (Basel) 2020;12:E3529. [PMID: 33256070 DOI: 10.3390/cancers12123529] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
63 Martínez V, Abalo R. Peripherally acting opioid analgesics and peripherally-induced analgesia. Behav Pharmacol 2020;31:136-58. [PMID: 32168025 DOI: 10.1097/FBP.0000000000000558] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
64 Yang H, Xu D, Schmid RA, Peng RW. Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma. Ther Adv Med Oncol 2020;12:1758835920971421. [PMID: 33240401 DOI: 10.1177/1758835920971421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
65 Cambria MT, Villaggio G, Laudani S, Pulvirenti L, Federico C, Saccone S, Condorelli GG, Sinatra F. The Interplay between Fe3O4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport. Int J Mol Sci 2020;21:E8473. [PMID: 33187164 DOI: 10.3390/ijms21228473] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Jhawat V, Gulia M, Gupta S, Maddiboyina B, Dutt R. Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy. J Control Release 2020;327:500-11. [PMID: 32858073 DOI: 10.1016/j.jconrel.2020.08.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Arib C, Spadavecchia J. Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine. ACS Omega 2020;5:28483-92. [PMID: 33195898 DOI: 10.1021/acsomega.0c02644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Liang Z, Li J, Zhu B. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform. Drug Des Devel Ther 2020;14:4519-31. [PMID: 33149550 DOI: 10.2147/DDDT.S251749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Liao Z, Wong SW, Yeo HL, Zhao Y. Smart nanocarriers for cancer treatment: Clinical impact and safety. NanoImpact 2020;20:100253. [DOI: 10.1016/j.impact.2020.100253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
70 Ledezma-Gallegos F, Jurado R, Mir R, Medina LA, Mondragon-Fuentes L, Garcia-Lopez P. Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment. Pharmaceutics 2020;12:E897. [PMID: 32971785 DOI: 10.3390/pharmaceutics12090897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gurunathan S, Jeyaraj M, Kang MH, Kim JH. Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer. Int J Mol Sci 2020;21:E6792. [PMID: 32947930 DOI: 10.3390/ijms21186792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
72 Vicente‐ruiz S, Serrano‐martí A, Armiñán A, Vicent MJ. Nanomedicine for the Treatment of Advanced Prostate Cancer. Adv Therap 2021;4:2000136. [DOI: 10.1002/adtp.202000136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Siddique S, Chow JCL. Application of Nanomaterials in Biomedical Imaging and Cancer Therapy. Nanomaterials (Basel) 2020;10:E1700. [PMID: 32872399 DOI: 10.3390/nano10091700] [Cited by in Crossref: 46] [Cited by in F6Publishing: 98] [Article Influence: 23.0] [Reference Citation Analysis]
74 Gurunathan S, Qasim M, Choi Y, Do JT, Park C, Hong K, Kim JH, Song H. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses? Nanomaterials (Basel) 2020;10:E1645. [PMID: 32825737 DOI: 10.3390/nano10091645] [Cited by in Crossref: 39] [Cited by in F6Publishing: 77] [Article Influence: 19.5] [Reference Citation Analysis]
75 Borys F, Joachimiak E, Krawczyk H, Fabczak H. Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells. Molecules 2020;25:E3705. [PMID: 32823874 DOI: 10.3390/molecules25163705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
76 Korupalli C, Kalluru P, Nuthalapati K, Kuthala N, Thangudu S, Vankayala R. Recent Advances of Polyaniline-Based Biomaterials for Phototherapeutic Treatments of Tumors and Bacterial Infections. Bioengineering (Basel) 2020;7:E94. [PMID: 32823566 DOI: 10.3390/bioengineering7030094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
77 Munawer U, Raghavendra VB, Ningaraju S, Krishna KL, Ghosh AR, Melappa G, Pugazhendhi A. Biofabrication of gold nanoparticles mediated by the endophytic Cladosporium species: Photodegradation, in vitro anticancer activity and in vivo antitumor studies. Int J Pharm 2020;588:119729. [PMID: 32768527 DOI: 10.1016/j.ijpharm.2020.119729] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
78 Purushothaman B, Lee J, Hong S, Song JM. Multifunctional TPP-PEG-biotin self-assembled nanoparticle drug delivery-based combination therapeutic approach for co-targeting of GRP78 and lysosome. J Nanobiotechnology 2020;18:102. [PMID: 32690101 DOI: 10.1186/s12951-020-00661-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
79 Jain V, Kumar H, Anod HV, Chand P, Gupta NV, Dey S, Kesharwani SS. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J Control Release 2020;326:628-47. [PMID: 32653502 DOI: 10.1016/j.jconrel.2020.07.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
80 Cirillo G, Peitzsch C, Vittorio O, Curcio M, Farfalla A, Voli F, Dubrovska A, Iemma F, Kavallaris M, Hampel S. When polymers meet carbon nanostructures: expanding horizons in cancer therapy. Future Med Chem 2019;11:2205-31. [PMID: 31538523 DOI: 10.4155/fmc-2018-0540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Cleland DM, Fletcher EK, Kuperman A, Per MC. Electron correlation effects in isomers of C 20. J Phys Mater 2020;3:025006. [DOI: 10.1088/2515-7639/ab7e41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
82 Wang H, Huang Y. Combination therapy based on nano codelivery for overcoming cancer drug resistance. Medicine in Drug Discovery 2020;6:100024. [DOI: 10.1016/j.medidd.2020.100024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
83 Karuppaiah A, Siram K, Selvaraj D, Ramasamy M, Babu D, Sankar V. Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells. Materials Today Communications 2020;23:100884. [DOI: 10.1016/j.mtcomm.2019.100884] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
84 Daryanavard M, Jannesari Z, Javeri M, Abyar F. A new mononuclear zinc(II) complex: Crystal structure, DNA- and BSA-binding, and molecular modeling; in vitro cytotoxicity of the Zn(II) complex and its nanocomplex. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020;233:118175. [DOI: 10.1016/j.saa.2020.118175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
85 Lepeltier E, Rijo P, Rizzolio F, Popovtzer R, Petrikaite V, Assaraf YG, Passirani C. Nanomedicine to target multidrug resistant tumors. Drug Resist Updat 2020;52:100704. [PMID: 32512316 DOI: 10.1016/j.drup.2020.100704] [Cited by in Crossref: 22] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
86 Farzin A, Etesami SA, Quint J, Memic A, Tamayol A. Magnetic Nanoparticles in Cancer Therapy and Diagnosis. Adv Healthc Mater 2020;9:e1901058. [PMID: 32196144 DOI: 10.1002/adhm.201901058] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 49.5] [Reference Citation Analysis]
87 AbuMousa RA, Baig U, Gondal MA, Dastageer MA, AlSalhi MS, Moftah B, Yahya Alqahtani F, Akhter S, Sfouq Aleanizy F. Investigation of the survival viability of cervical cancer cells (HeLa) under visible light induced photo-catalysis with facile synthesized WO3/ZnO nanocomposite. Saudi J Biol Sci 2020;27:1743-52. [PMID: 32565691 DOI: 10.1016/j.sjbs.2020.04.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Mello FVC, de Moraes GN, Maia RC, Kyeremateng J, Iram SH, Santos-Oliveira R. The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein. Int J Mol Sci 2020;21:E2630. [PMID: 32290047 DOI: 10.3390/ijms21072630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
89 Tang Q, Yin D, Wang Y, Du W, Qin Y, Ding A, Li H. Cancer Stem Cells and Combination Therapies to Eradicate Them. Curr Pharm Des 2020;26:1994-2008. [PMID: 32250222 DOI: 10.2174/1381612826666200406083756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Cobos M, De-La-Pinta I, Quindós G, Fernández MJ, Fernández MD. Graphene Oxide-Silver Nanoparticle Nanohybrids: Synthesis, Characterization, and Antimicrobial Properties. Nanomaterials (Basel) 2020;10:E376. [PMID: 32098083 DOI: 10.3390/nano10020376] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
91 Abdel-ghany S, Mahfouz M, Ashraf N, Sabit H, Cevik E, El-zawahri M. Gold nanoparticles induce G2/M cell cycle arrest and enhance the expression of E-cadherin in breast cancer cells. Inorganic and Nano-Metal Chemistry 2020;50:926-32. [DOI: 10.1080/24701556.2020.1728553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Misra R, Kandoi S, Varadaraj S, Vijayalakshmi S, Nanda A, Verma RS. Nanotheranostics: A tactic for cancer stem cells prognosis and management. Journal of Drug Delivery Science and Technology 2020;55:101457. [DOI: 10.1016/j.jddst.2019.101457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
93 Sarkar S, Levi-Polyachenko N. Conjugated polymer nano-systems for hyperthermia, imaging and drug delivery. Adv Drug Deliv Rev 2020;163-164:40-64. [PMID: 32001326 DOI: 10.1016/j.addr.2020.01.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 21.0] [Reference Citation Analysis]
94 Voci S, Gagliardi A, Fresta M, Cosco D. Antitumor Features of Vegetal Protein-Based Nanotherapeutics. Pharmaceutics 2020;12:E65. [PMID: 31952147 DOI: 10.3390/pharmaceutics12010065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
95 Shukla RP, Dewangan J, Urandur S, Banala VT, Diwedi M, Sharma S, Agrawal S, Rath SK, Trivedi R, Mishra PR. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma. Biomater Sci 2020;8:1298-315. [DOI: 10.1039/c9bm01246j] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
96 Anwar A, Mungroo MR, Anwar A, Sullivan WJ Jr, Khan NA, Siddiqui R. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae Acanthamoeba castellanii and Naegleria fowleri. ACS Infect Dis 2019;5:2039-46. [PMID: 31612700 DOI: 10.1021/acsinfecdis.9b00263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
97 Slika L, Patra D. A short review on chemical properties, stability and nano-technological advances for curcumin delivery. Expert Opin Drug Deliv 2020;17:61-75. [PMID: 31810374 DOI: 10.1080/17425247.2020.1702644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
98 Vakilinezhad MA, Amini A, Dara T, Alipour S. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation. Colloids and Surfaces B: Biointerfaces 2019;184:110515. [DOI: 10.1016/j.colsurfb.2019.110515] [Cited by in Crossref: 22] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
99 Yurchenko A, Nikitina N, Sokolova V, Prylutska S, Kuziv Y, Virych P, Chumachenko V, Kutsevol N, Ponomarenko S, Prylutskyy Y, Epple M. A Novel Branched Copolymer-Containing Anticancer Drug for Targeted Therapy: In Vitro Research. BioNanoSci 2020;10:249-59. [DOI: 10.1007/s12668-019-00700-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
100 Singh R, Kumar CS, Banerjee M, Gupta S. A Dual Drug Delivery Platform for Cancer–Bacteria Cotargeting. ACS Appl Bio Mater 2019;2:5032-41. [DOI: 10.1021/acsabm.9b00724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Wijetunge SS, Wen J, Yeh CK, Sun Y. Wheat germ agglutinin liposomes with surface grafted cyclodextrins as bioadhesive dual-drug delivery nanocarriers to treat oral cells. Colloids Surf B Biointerfaces 2020;185:110572. [PMID: 31654890 DOI: 10.1016/j.colsurfb.2019.110572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
102 Odularu AT, Ajibade PA, Mbese JZ. Impact of Molybdenum Compounds as Anticancer Agents. Bioinorg Chem Appl 2019;2019:6416198. [PMID: 31582964 DOI: 10.1155/2019/6416198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
103 Wu W, Klockow JL, Mohanty S, Ku KS, Aghighi M, Melemenidis S, Chen Z, Li K, Morais GR, Zhao N, Schlegel J, Graves EE, Rao J, Loadman PM, Falconer RA, Mukherjee S, Chin FT, Daldrup-Link HE. Theranostic nanoparticles enhance the response of glioblastomas to radiation. Nanotheranostics 2019;3:299-310. [PMID: 31723547 DOI: 10.7150/ntno.35342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
104 Cortese B, D'Amone S, Testini M, Ratano P, Palamà IE. Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy. Cancers (Basel) 2019;11:E1338. [PMID: 31510037 DOI: 10.3390/cancers11091338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
105 Cirillo G, Vittorio O, Kunhardt D, Valli E, Voli F, Farfalla A, Curcio M, Spizzirri UG, Hampel S. Combining Carbon Nanotubes and Chitosan for the Vectorization of Methotrexate to Lung Cancer Cells. Materials (Basel) 2019;12:E2889. [PMID: 31500165 DOI: 10.3390/ma12182889] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
106 Raju GSR, Dariya B, Mungamuri SK, Chalikonda G, Kang SM, Khan IN, Sushma PS, Nagaraju GP, Pavitra E, Han YK. Nanomaterials multifunctional behavior for enlightened cancer therapeutics. Semin Cancer Biol 2021;69:178-89. [PMID: 31419527 DOI: 10.1016/j.semcancer.2019.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
107 Chen Y, Li N, Xu B, Wu M, Yan X, Zhong L, Cai H, Wang T, Wang Q, Long F, Jiang G, Xiao H. Polymer-based nanoparticles for chemo/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma. Biomed Pharmacother 2019;118:109257. [PMID: 31377472 DOI: 10.1016/j.biopha.2019.109257] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
108 Harris R. Chemotherapy drug temozolomide adsorbed onto iron-oxide (Fe3O4) nanoparticles as nanocarrier: A simulation study. Journal of Molecular Liquids 2019;288:111084. [DOI: 10.1016/j.molliq.2019.111084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
109 Gurunathan S, Jeyaraj M, Kang MH, Kim JH. Tangeretin-Assisted Platinum Nanoparticles Enhance the Apoptotic Properties of Doxorubicin: Combination Therapy for Osteosarcoma Treatment. Nanomaterials (Basel) 2019;9:E1089. [PMID: 31362420 DOI: 10.3390/nano9081089] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
110 Elias L, Taengua R, Frígols B, Salesa B, Serrano-Aroca Á. Carbon Nanomaterials and LED Irradiation as Antibacterial Strategies against Gram-Positive Multidrug-Resistant Pathogens. Int J Mol Sci 2019;20:E3603. [PMID: 31340560 DOI: 10.3390/ijms20143603] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
111 Jeon J. Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials. Int J Mol Sci 2019;20:E2323. [PMID: 31083402 DOI: 10.3390/ijms20092323] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
112 Yu J, Dong HW, Shi LT, Tang XY, Liu JR, Shi JH. Reproductive toxicity of perchlorate in rats. Food Chem Toxicol 2019;128:212-22. [PMID: 30991129 DOI: 10.1016/j.fct.2019.04.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
113 Truffi M, Mazzucchelli S, Bonizzi A, Sorrentino L, Allevi R, Vanna R, Morasso C, Corsi F. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy. Int J Mol Sci 2019;20:E1263. [PMID: 30871158 DOI: 10.3390/ijms20061263] [Cited by in Crossref: 29] [Cited by in F6Publishing: 43] [Article Influence: 9.7] [Reference Citation Analysis]
114 Ghawanmeh AA, Ali GAM, Algarni H, Sarkar SM, Chong KF. Graphene oxide-based hydrogels as a nanocarrier for anticancer drug delivery. Nano Res 2019;12:973-90. [DOI: 10.1007/s12274-019-2300-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]